Abstract
El virus SARS-COV-2 desencadena una respuesta inmunitaria antitumoral en un paciente con linfoma
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Revista Española de Medicina Nuclear e Imagen Molecular
Paper Title
Journal
Date
